Search Results 321-330 of 11006 for SC

  1. Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol - Mayo Clinic

    ... (SC) inclisiran injection(s). The study will be a multicenter study in the United States. Participation eligibility. Participant eligibility includes age ...

  2. How the program works - Mayo Clinic

    SC: Mayo Clinic Breadcrumb. Home · Complex Care Program. Sections Complex Care Program. Program Overview · How the program works · Get Started. Print. How the ...

  3. Publications - Niti R. Aggarwal, M.D. - Mayo Clinic

    ... SC, Sweitzer B, Talbot AW, Vallabhajosyula S, Whittle J, Williams KA Sr, Writing Committee Members. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline ...

  4. Publications - Michael Gharacholou, M.D., M.S. - Mayo Clinic

    ... SC. Characteristics and outcomes of patients with peripheral artery disease undergoing endovascular revascularization: A community hospital perspective ...

  5. Eddie L. Greene, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... South Carolina. 1999 - 2000. FellowSouthern Society for Clinical ... MemberDiabetes Initiative of South Carolina, Medical University of South Carolina.

  6. A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 - Mayo Clinic

    ... (SC) for an additional 20 Weeks after completing the 32 Week study assessments post-randomization, while they continue with their background HES therapy per ...

  7. Publications - Wolfgang Singer, M.D. - Mayo Clinic

    Is EE, Ciftci Inceoglu S, Tekin SC, Albayrak B, Sonsoz MR, Kuran B, Singer W. Validation and reliability of the Turkish version of the composite autonomic ...

  8. Tamas Ordog, M.D. - Mayo Clinic Faculty Profiles

    ... Sc. Department of Physiology, University of Pecs Medical School; MD - Research Thesis: Interactions between membrane-bound and intracellular hormone ...

  9. A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/​or Subacute Cutaneous Lupus Erythematosus (LAVENDER) - Mayo Clinic

    This study aims to evaluate the efficacy and safety of subcutaneous (SC) anifrolumab versus placebo in adult participants with cutaneous lupus erythematosus ( ...

  10. Colon Adenocarcinoma Clinical Trials - Mayo Clinic Research

    This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...